XIIth International Myeloma Workshop in Washington, DCOn-Demand Only Session: Clinical - New Agents
Chairs: Alok Sharma, M.D., Meletios Dimopoulos, M.D.
February 27, 2009, 13:30 - 13:45 Eastern Standard Time
Phase I Study of Elotuzumab (HuLuc63) in Combination with Bortezomib in Relapsed Multiple Myeloma
Dr. Andrzej Jakubowiak
University of Michigan Cancer Center, Ann Arbor, Michigan
Back to the Meeting Index